• Home
• News
• Cruise Ships
• New Ships
• Cruise Lines
• PSA

Carnival Ecstasy launches first four and five-day Bahamas cruises from Port Canaveral

Carnival Cruise Lines launched the cruise industry’s only four and five-day Bahamas/Caribbean program from Port Canaveral on Monday (November 7) with the first sailing of Carnival Ecstasy.

The sold-out cruise to Nassau, Freeport and the private Bahamian island of Half Moon Cay is the first of 78 annual voyages from the Space Coast.

Carnival Ecstasy’s one-of-a-kind schedule includes two different four-day itineraries, along with two different five-day choices.

Carnival Ecstasy now offers four and five-day Bahamas cruises

Four-day “long weekend” cruises depart Thursdays and visit Nassau and Half Moon Cay or Freeport, while five-day voyages depart Mondays and Saturdays, calling at Nassau, Freeport and Half Moon Cay or Key West.

These cruises have non-refundable Early Saver rates starting at $329 per person for four-day voyages and $349 per person for five-day departures.

The new program further bolsters the line’s position as Port Canaveral’s largest cruise operator with three year-round ships carrying approximately 600,000 guests annually.

Combined with Carnival Sensation’s three and four-day Bahamas cruises and Carnival Dream’s seven-day eastern and western Caribbean voyages, the line offers an unprecedented variety of itineraries, cruise lengths, and departure days from Port Canaveral.

“The growth of Port Canaveral as a cruise departure point is truly extraordinary and millions of consumers have discovered the benefits of sailing from this convenient and centrally located homeport,” said Carnival president Gerry Cahill.

According to Port Canaveral CEO Stan Payne, “The Carnival Ecstasy’s arrival comes only a few days after we shattered our record for cruise passengers at Port Canaveral. Our success in providing customers, guests and our cruise partners with world-class service and facilities has resulted in momentum that will be richly enhanced by the Carnival Ecstasy.”